Novel drug delivery approach that utilizes long-acting injectable microcrystals may enable new options for long-term delivery ...

Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

Researchers suggest discoveries may lead to new strategies for treating skin diseases, inflammation, diabetes, and ...

Scientists suggest study findings could point to the future development of new treatments for age-related cognitive decline.

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

New research suggests that VREfm have the ability to produce bacteriocin, an antimicrobial that can kill or inhibit other ...

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...

Cellares’ Cell Shuttle performed all unit operations in an automated manner, including cell isolation, enrichment, gene ...

Research lead Sven-Erik Behrens, PhD, at the Institute of Biochemistry and Biotechnology at MLU, and colleagues, reported ...

The patient, whom Sarepta described as a young man and later told news outlets was 16 years old, suffered acute liver failure ...

Tumor inflitrating lymphocyte therapies are a promising type of cellular immunotherapy used to treat a broad range of solid ...

In a new study, results suggest that in a preclinical model, two FDA-approved flu antivirals did not successfully treat ...